Crystal structure of human cholesterol sulfotransferase (SULT2B1b) in the presence of pregnenolone and 3′-phosphoadenosine 5′-phosphate -: Rationale for specificity differences between prototypical SULT2A1 and the SULT2B1 isoforms

被引:56
作者
Lee, KA
Fuda, H
Lee, YC
Negishi, M
Strott, CA
Pedersen, LC
机构
[1] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA
[2] NIEHS, Pharmacogenet Sect, Reprod & Dev Toxicol Lab, NIH, Res Triangle Pk, NC 27709 USA
[3] NICHD, Sect Steroid Regulat, Endocrinol & Reprod Res Branch, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1074/jbc.M308312200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The gene for human hydroxysteroid sulfotransferase (SULT2B1) encodes two peptides, SULT2B1a and SULT2B1b, that differ only at their amino termini. SULT2B1b has a predilection for cholesterol but is also capable of sulfonating pregnenolone, whereas SULT2B1a preferentially sulfonates pregnenolone and only minimally sulfonates cholesterol. We have determined the crystal structure of SULT2B1a and SULT2B1b bound to the substrate donor product 3'-phosphoadenosine 5'-phosphate at 2.9 and 2.4 Angstrom, respectively, as well as SULT2B1b in the presence of the acceptor substrate pregnenolone at 2.3 Angstrom. These structures reveal a different catalytic binding orientation for the substrate from a previously determined structure of hydroxysteroid sulfotransferase (SULT2A1) binding dehydroepiandrosterone. In addition, the amino-terminal helix comprising residues Asp(19) to Lys(26), which determines the specificity difference between the SULT2B1 isoforms, becomes ordered upon pregnenolone binding, covering the substrate binding pocket.
引用
收藏
页码:44593 / 44599
页数:7
相关论文
共 32 条
[31]   Conservation of the hydroxysteroid sulfotransferase SULT2B1 gene structure in the mouse:: Pre- and postnatal expression, kinetic analysis of isoforms, and comparison with prototypical SULT2A1 [J].
Shimizu, C ;
Fuda, H ;
Yanai, H ;
Strott, CA .
ENDOCRINOLOGY, 2003, 144 (04) :1186-1193
[32]   Sulfonation and molecular action [J].
Strott, CA .
ENDOCRINE REVIEWS, 2002, 23 (05) :703-732